ARCHIVES

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

August 31, 2001

Blinatumomab Demonstrates High Response Rate in ALL

June 29, 2012

Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering

September 3, 2010

CCOP Pink Sheets Go Out, Details Starting to Emerge On Number Of Awards, Payline, Possible Exceptions

May 6, 1983

NCI to Expand Quality of Care Research, Lead HHS Panel On Cancer Care Policy.

October 1, 1999

In Brief: Harold Douglass New GITSG Chairman: NTP Deputy Chief Moore to Be Nominated For Top EPA Position

August 5, 1983